Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 16 | 0 | 4 | 0 | €98.63 | €116.81 | 18.430% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.75 | - | - |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €40.00 | €82.93 | 107.328% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €39.40 | €46.08 | 16.961% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |
| Bayer AG | 15 | 1 | 0 | 0 | €28.22 | €50.00 | 77.211% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.96 | €8.39 | 326.996% |
| Halozyme Therapeutics Inc. | 13 | 0 | 2 | 0 | €37.15 | €53.50 | 43.998% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €19.30 | €28.17 | 45.984% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €18.40 | €38.19 | 107.574% |
| Stoke Therapeutics Inc | 13 | 1 | 2 | 0 | €11.20 | €21.00 | 87.532% |
| Insmed Inc. | 13 | 1 | 2 | 1 | €23.80 | €44.01 | 84.902% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.63 | €4.63 | 27.538% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | €46.20 | - | - |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €60.02 | €86.77 | 44.570% |
| Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 0 | 0 | €13.00 | €13.50 | 3.846% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €21.98 | €35.43 | 61.189% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.00 | €23.46 | 67.599% |
| Alkermes plc | 12 | 2 | 1 | 0 | €22.00 | €34.08 | 54.912% |
| Incyte Corp. | 12 | 2 | 3 | 1 | €49.57 | €78.42 | 58.205% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €10.00 | €27.03 | 170.310% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €368.80 | €421.61 | 14.318% |